medigraphic.com
Colegio de Medicina Interna de México.

2021, Number 6

<< Back Next >>

Med Int Mex 2021; 37 (6)

Economic and confinement factors influence self-care activities during COVID-19 pandemic in patients with type 2 diabetes

González-Cantú A, Silva-Tinoco R, De la Torre-Saldaña VA, Ferreira-Hermosillo A, Cuatecontzi-Xochitiotzi T, Ochoa-Moreno J

Language: Spanish
References: 23
Page: 962-970
PDF size: 217.25 Kb.


ABSTRACT

Objective: To assess the barriers to self-care and adherence to medication during confinement for COVID-19 in patients with type 2 diabetes.
Materials and Methods: An observational, cross-sectional and longitudinal study was done in patients with type 2 diabetes, the diabetes self-care activities summary tool was used to compare self-care behaviors and the 8-item Morisky-Green questionnaire to assess adherence to medication from April 20 to May 29, 2020. A questionnaire designed by the research team was used to assess difficulties in coping with type 2 diabetes. A multiple linear regression model was used to predict the association between the presence of difficulties and self-care.
Results: The frequency of self-care activities decreased for diet (p ‹ 0.008), physical activity/exercise (p ‹ 0.054) and glucose monitoring (p ‹ 0.001). Lack of economic resources was an inverse predictor for adherence to diet (p ‹ 0.001) and glucose monitoring (p ‹ 0.001), and the confinement barrier was an inverse predictor for adherence to diet (p ‹ 0.001) and activity physical/exercise (p ‹ 0.001).
Conclusions: Economic and confinement barriers were predictors for the execution of self-care behaviors independently.


REFERENCES

  1. Hernández-Galdamez DR, González-Block MÁ, Romo- Dueñas DK, Lima-Morales R, Hernández-Vicente IA, Lumbreras-Guzmán M, Méndez-Hernández P. Increased risk of hospitalization and death in patients with COVID-19 and pre-existing noncommunicable diseases and modifiable risk factors in Mexico. Arch Med Res 2020; 51 (7): 683-689. doi: 10.1016/j.arcmed.2020.07.003.

  2. Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr 2020; 14 (4): 303-310. doi: 10.1016/j.dsx.2020.04.004.

  3. Lim MA, Huang I, Yonas E, Vania R, Pranata R. A wave of non-communicable diseases following the COVID-19 pandemic. Diabetes Metab Syndr 2020; 14 (5): 979-980. doi: 10.1016/j.dsx.2020.06.050.

  4. Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020; 17 (5): 1729. doi: 10.3390/ ijerph17051729.

  5. Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic. Diabetes Metab Syndr 2020; 14 (4): 351-354. doi: 10.1016/j.dsx.2020.04.013.

  6. Ausili D, Bulgheroni M, Ballatore P, Specchia C, Ajdini A, Bezze S, Di Mauro S, Genovese S. Self-care, quality of life and clinical outcomes of type 2 diabetes patients: an observational cross-sectional study. Acta Diabetol 2017; 54 (11): 1001-1008. doi: 10.1007/s00592-017-1035-5.

  7. Silva-Tinoco R, Cuatecontzi-Xochitiotzi T, De la Torre-Saldaña V, León-García E, Serna-Alvarado J, Guzmán-Olvera E, Cabrera D, Gay JG, Prada D. Role of social and other determinants of health in the effect of a multicomponent integrated care strategy on type 2 diabetes mellitus. Int J Equity Health 2020; 19 (1): 75. doi: 10.1186/s12939-020-01188-2.

  8. Shrivastava SR, Shrivastava PS, Ramasamy J. Role of selfcare in management of diabetes mellitus. J Diabetes Metab Disord 2013; 12 (1): 14. doi: 10.1186/2251-6581-12-14.

  9. Silva-Tinoco R, González-Cantú A, De La Torre-Saldaña V, Guzmán-Olvera E, Cuatecontzi-Xochitiotzi T, Castillo- Martínez-Lilia, et al. In press. Effect in self-care behavior and difficulties in coping with diabetes during the COVID-19 pandemic. Rev Mex Endocrinol Metab Nutr 2021; 8: 13-9. doi: 10.24875/RME.20000063.

  10. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology 2007; 18 (6): 805-35. doi: 10.1097/EDE.0b013e3181577511.

  11. Delatorre-Saldaña VA, Silva-Tinoco R, Hernández J, Guzmán EB, Castillo-Martínez L, Orea-Tejeda A, et al. 655-P: Effect of an Interdisciplinary care and diabetes self-management education program on weight among persons with social and clinical complex profile. Diabetes 2019; 68 (Supplement 1). https://doi.org/10.2337/db19-655-P.

  12. Secretaría de Salud. 24 de marzo de 2020. 095. Inicia fase 2 por coronavirus COVID-19. https://www.gob.mx/salud/ prensa/095-inicia-fase-2-por-coronavirus-covid-19.

  13. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10 (5): 348-54. doi: 10.1111/j.1751-7176.2008.07572.x.

  14. Bermeo-Cabrera J, Almeda-Valdes P, Riofrios-Palacios J, Aguilar-Salinas CA, Mehta R. Insulin adherence in type 2 diabetes in Mexico: Behaviors and barriers. J Diabetes Res 2018; 2018:3190849. doi: 10.1155/2018/3190849. PMID: 30116737.

  15. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care 2000; 23 (7): 943-50. doi: 10.2337/diacare.23.7.943.

  16. Ding D, Del Pozo Cruz B, Green MA, Bauman AE. Is the COVID-19 lockdown nudging people to be more active: a big data analysis. Br J Sports Med 2020; 54 (20): 1183-1184. doi: 10.1136/bjsports-2020-102575.

  17. Bambra C, Riordan R, Ford J, Matthews F. The COVID-19 pandemic and health inequalities. J Epidemiol Community Health 2020; 74 (11): 964-968. doi: 10.1136/jech-2020- 214401.

  18. Ghosal S, Sinha B, Majumder M, Misra A. Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis. Diabetes Metab Syndr 2020; 14 (4): 319-323. doi: 10.1016/j.dsx.2020.03.014.

  19. Hernández-Jiménez S, García-Ulloa AC, Bello-Chavolla OY, Aguilar-Salinas CA, Kershenobich-Stalnikowitz D; Group of Study CAIPaDi. Long-term effectiveness of a type 2 diabetes comprehensive care program. The CAIPaDi model. Diabetes Res Clin Pract 2019; 151: 128-137. doi: 10.1016/j. diabres.2019.04.009.

  20. Whittemore R, Vilar-Compte M, De La Cerda S, Delvy R, Jeon S, Burrola-Méndez S, Pardo-Carrillo M, Lozano- Marrufo A, Pérez-Escamilla R. ¡Sí, Yo Puedo Vivir Sano con Diabetes! A self-management randomized controlled pilot trial for low-income adults with type 2 diabetes in Mexico City. Curr Dev Nutr 2020; 4 (5): nzaa074. doi: 10.1093/ cdn/nzaa074.

  21. Misra A, Bloomgarden Z. Diabetes during the COVID-19 pandemic: A global call to reconnect with patients and emphasize lifestyle changes and optimize glycemic and blood pressure control. J Diabetes 2020; 12 (7): 556-557. doi: 10.1111/1753-0407.13048.

  22. Gujral UP, Johnson L, Nielsen J, Vellanki P, Haw JS, Davis GM, Weber MB, Pasquel FJ. Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks. BMJ Open Diabetes Res Care 2020; 8 (1): e001520. doi: 10.1136/bmjdrc-2020-001520.

  23. Silva-Tinoco R, De la Torre-Saldaña V. La imperiosa necesidad de telemedicina en la atención de diabetes durante la pandemia de COVID-19. Un estudio de abordaje integral. Gac Med Mex 2021; 157: 323-326. DOI: 10.24875/ GMM.20000674.




2020     |     www.medigraphic.com